1. Healthcare resource use and cost associated with varying dosages of extended corticosteroid exposure in a US population. (2nd September 2018) Authors: Rice, J. Bradford; White, Alan G.; Johnson, Michaela; Wagh, Aneesha; Qin, Yimin; Bartels-Peculis, Laura; Ciepielewska, Gosia; Nelson, Winnie W. Journal: Journal of medical economics Issue: Volume 21:Number 9(2018) Page Start: 846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants. (1st December 2020) Authors: Fermann, Gregory J.; Lovelace, Belinda; Christoph, Mary J.; Lingohr-Smith, Melissa; Lin, Jay; Deitelzweig, Steven B. Journal: Journal of medical economics Issue: Volume 23:Number 12(2021) Page Start: 1409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Total cost of care for castration-resistant prostate cancer in a commercially insured population and a medicare supplemental insured population. (2nd January 2020) Authors: Wu, Bingcao; Li, Sophia S.; Song, Ji; Pericone, Christopher D.; Behl, Ajay S.; Dawson, Nancy A. Journal: Journal of medical economics Issue: Volume 23:Number 1(2020) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA. (1st December 2020) Authors: Deitelzweig, Steven; Dhamane, Amol D.; Di Fusco, Manuela; Russ, Cristina; Rosenblatt, Lisa; Lingohr-Smith, Melissa; Lin, Jay Journal: Journal of medical economics Issue: Volume 23:Number 12(2021) Page Start: 1389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗